Scott C. Shepherd
Midland Road
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Journal: Nature
Published: January 14, 2026
Fatal intracranial haemorrhage shortly after belzutifan initiation in von Hippel-Lindau (VHL) disease-associated haemangioblastoma.
Journal: ESMO open
Published: April 14, 2025
Preparation for Practice: Facilitating the Transition From Student to Physician Associate.
Journal: The clinical teacher
Published: July 17, 2024
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC).
Journal: Stem cell research
Published: April 24, 2024
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal.
Journal: Cancer discovery
Published: April 09, 2024
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.
Journal: Cancer discovery
Published: April 09, 2024
Saturation genome editing maps the functional spectrum of pathogenic VHL alleles.
Journal: Nature genetics
Published: May 11, 2023
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: January 10, 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Journal: Cancer discovery
Published: December 20, 2022
The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 15, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Journal: Cell reports. Medicine
Published: June 06, 2022
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Journal: Breast cancer research and treatment
Published: April 20, 2022
Last Updated: 09/26/2026